甲托雷克萨特用于儿科患者的炎症性皮肤病:共识治疗指南
Elaine C Siegfried1,2, Lisa M Arkin3, Yvonne E Chiu4
1SSM Cardinal Glennon Children's Hospital, St. Louis, Missouri, USA.
Pediatric dermatology
|June 14, 2023
概括
这项研究提供了专家共识的指导方针,用于使用甲状腺素 (MTX) 治疗儿科炎症性皮肤疾病. 这些建议旨在支持儿童安全有效地使用这种重要的药物.
科学领域:
- 皮肤病学 皮肤病学
- 儿科医学 儿科医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲托雷克萨特 (MTX) 被广泛用于儿童炎症性皮肤疾病的非标签.
- 目前的FDA标签缺乏许多儿童这些疾病的批准指示.
- 缺乏指导方针可能会导致临床医生在为儿科患者处方MTX时犹不决.
研究的目的:
- 制定基于证据和共识的MTX在儿科炎性皮肤疾病中的使用指南.
- 为了解决这一患者群体对明确治疗方案的未满足需求.
- 支持临床医生在安全有效的MTX处方.
主要方法:
- 专家共识委员会召开,由儿科皮肤病学和MTX治疗专家组成.
- 五个小组委员会专注于说明,剂量,药物相互作用,不良反应和监测.
- 修改后的Delphi流程被采用,以达成关于建议的协议.
主要成果:
- 该委员会制定了46项基于证据和共识的建议.
- 所有建议在委员会成员之间达成>70%的共识.
- 这些指南涵盖了适应症,适应症,剂量,相互作用,不良反应和监测.
结论:
- 这些指导方针为儿童炎症性皮肤疾病中安全有效使用甲状腺素提供了框架.
- 这些建议旨在授权临床医生在服务不足的儿科患者中使用MTX.
- 这项工作支持适当应用一种有价值,成熟的药物.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
202
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
202
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
161
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
161
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
177
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
177
Inflammatory Bowel Disease IV: Pharmacological Management
158
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
158
Skin Diseases and Disorders
3.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.9K
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K


